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Introduction: Acetyl-L-Carnitine (ALC), a natural occurring compound in all mammalian 
species, plays a variety of vital functions in the body. The most important are related to 
mitochondria, namely the transport of fatty acids for energy production through β oxidation 
and the control of acyl-CoA/CoA ratio. Due to this close interaction with cell bioenergetics, it 
plays a role in many diseases, especially those related to the mitochondria. We propose to 
characterize the action of ALC in mitochondrial bioenergetics and functional integrity. 
Material and Methods: Rat pheochromocytoma cells (PC12) were exposed to the toxic effects 
of methamphetamine (METH 1 and 100 M) and pretreated with different doses of ALC (0.01, 
0.1 and 1.0 mM). After 24 or 72h of incubation, mitochondrial function, ATP production, 
intracellular reactive oxygen species (ROS) and mitochondrial membrane potential were 
assessed by using, respectively, Mitotracker CMXRos, CellTiter-Glo® kit, dichlorofluorescein 
diacetate probe (DCF-DA) and 99mTc-sestamibi uptake. Mitochondrial function and intracellular 
ROS were assessed by flow cytometry and fluorescence microscopy, ATP production was 
assessed by luminescence and mitochondrial membrane potential was assessed through the 
quantification of 99mTc-sestamibi uptake by the cells after a period of 45 minutes of incubation 
with 740 kBq/mL. 
Results: ALC was effective in preventing the deleterious effects of METH on mitochondrial 
function caused by a 72h exposure, particularly significant when cells were treated with 1.0 
M of METH (p<0.01). Cells treated with ALC alone or in combination with METH exhibited 
consistently lower ATP levels comparing to control cells, with higher significance for 72h 
exposure. METH enhanced the production of intracellular ROS which was reduced by pre-
treating cells with ALC, particularly when cells were treated with the ALC 0.01 mM. Although 
not enough to reach significance, exposure to METH 100 M for 72h increases 99mTc-sestamibi 
uptake, indicating mitochondrial membrane potential augmentation. This may represent 
 mitochondrial metabolism hyperactivation in order to counteract  the damaging effect of 
METH. Lower doses of ALC decreases slightly 99mTc-sestamibi utpake for the 72h exposure to 
METH 100 M. 
Conclusion: ALC exert its protective role by acting at the mitochondrial level, being able not 
only to improve mitochondrial function but also to improve cell bioenergetics, being effective 
in protecting cells against a variety of drugs known to cause oxidative stress, such as METH. 
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